Enveric Biosciences Announces 1-for-12 Reverse Stock Split
Enveric Biosciences Inc. will execute a 1-for-12 reverse stock split of its common stock, effective October 28, 2025. This action will decrease the number of shares outstanding from approximately 6.2 million to about 518,000. The shares will continue trading on the Nasdaq Capital Market under the symbol "ENVB" on a split-adjusted basis.
Enveric Biosciences Inc. will implement a 1-for-12 reverse stock split of its common stock, effective October 28, 2025. The move will reduce the number of shares outstanding from approximately 6.2 million to about 518,000. Enveric’s shares will continue trading on the Nasdaq Capital Market under the symbol “ENVB” on a split-adjusted basis. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251023433331) on October 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
